(Q41607770)

5 October 2017

1 reference

title

Factors controlling ocular angiogenesis (English)

1 reference

5 October 2017

R Casey

1

1 reference

5 October 2017

W W Li

series ordinal

2

1 reference

5 October 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

American Journal of Ophthalmology

5 October 2017

published in

1 reference

5 October 2017

volume

124

1 reference

5 October 2017

issue

4

1 reference

5 October 2017

page(s)

521-529

1 reference

Tumor angiogenesis: therapeutic implications

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Mechanisms of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Hypoxic regulation of vascular endothelial growth factor in retinal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Altered distribution of basic fibroblast growth factor in diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Cellular markers that distinguish the phases of hemangioma during infancy and childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Isolation of putative progenitor endothelial cells for angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Angiostatin induces and sustains dormancy of human primary tumors in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Interferon alpha 2a for treatment of age-related macular degeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

A pilot study of chronic recombinant interferon-alfa 2a for diabetic proliferative retinopathy: metabolic effects and opthalmologic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Thalidomide is an inhibitor of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

Antisense-oligonucleotide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2970868-2

10.1016/S0002-9394(14)70868-2

7 January 2021

Identifiers

DOI

1 reference

5 October 2017

1 reference